Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Debopam Samanta

Concepts (329)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Epilepsy
28
2024
176
13.000
 Why?
Seizures
22
2024
195
5.660
 Why?
Anticonvulsants
14
2024
121
5.510
 Why?
Tuberous Sclerosis
7
2024
36
4.330
 Why?
Spasms, Infantile
10
2024
28
4.210
 Why?
Cannabidiol
7
2024
35
4.030
 Why?
Status Epilepticus
6
2021
36
3.490
 Why?
Epilepsies, Myoclonic
5
2024
12
3.250
 Why?
Mutation
16
2023
1292
3.190
 Why?
Deep Brain Stimulation
4
2025
43
2.960
 Why?
Electroencephalography
18
2024
304
2.630
 Why?
Humans
110
2025
49929
2.590
 Why?
Intellectual Disability
5
2023
125
2.280
 Why?
Brain
10
2024
1310
2.230
 Why?
Child
39
2025
6849
2.170
 Why?
Hemiplegia
3
2021
10
2.110
 Why?
Developmental Disabilities
5
2019
119
1.760
 Why?
Epilepsy, Absence
3
2019
11
1.720
 Why?
Magnetic Resonance Imaging
15
2019
1526
1.640
 Why?
Tumor Suppressor Proteins
3
2023
127
1.470
 Why?
Neuroaxonal Dystrophies
2
2022
8
1.460
 Why?
Infant
21
2024
3575
1.450
 Why?
Nervous System Malformations
3
2020
18
1.450
 Why?
Folate Receptor 1
2
2022
25
1.430
 Why?
Epilepsies, Partial
2
2022
12
1.340
 Why?
Infant, Newborn, Diseases
2
2020
56
1.340
 Why?
Ketamine
2
2020
59
1.320
 Why?
Neurocutaneous Syndromes
2
2019
6
1.200
 Why?
Child, Preschool
19
2024
3879
1.190
 Why?
Cadherins
2
2019
64
1.180
 Why?
Cerebral Arteries
2
2019
37
1.100
 Why?
Epilepsy, Generalized
2
2023
8
1.090
 Why?
Vigabatrin
3
2024
3
1.070
 Why?
Sirolimus
2
2017
62
1.060
 Why?
Angiofibroma
2
2015
5
1.030
 Why?
Facial Neoplasms
2
2015
22
1.010
 Why?
Nerve Tissue Proteins
2
2018
192
1.000
 Why?
Valproic Acid
2
2022
32
0.990
 Why?
Vagus Nerve Stimulation
1
2025
12
0.970
 Why?
Stroke
3
2019
478
0.950
 Why?
Fenfluramine
2
2024
8
0.940
 Why?
Randomized Controlled Trials as Topic
2
2024
550
0.940
 Why?
Dioxolanes
2
2024
13
0.930
 Why?
Thalamus
1
2024
36
0.930
 Why?
Male
34
2024
25454
0.920
 Why?
Pregnanolone
2
2023
6
0.900
 Why?
Female
30
2024
26576
0.900
 Why?
Landau-Kleffner Syndrome
1
2022
3
0.850
 Why?
Treatment Outcome
10
2024
5178
0.820
 Why?
Quality Improvement
2
2022
205
0.820
 Why?
Aphasia
1
2022
32
0.810
 Why?
Nervous System Diseases
2
2021
88
0.790
 Why?
Chromosome Deletion
3
2019
138
0.780
 Why?
Abnormalities, Multiple
3
2023
167
0.770
 Why?
Emergencies
1
2021
84
0.740
 Why?
Algorithms
1
2024
613
0.740
 Why?
Pharmaceutical Preparations
1
2021
76
0.740
 Why?
Angelman Syndrome
1
2020
1
0.730
 Why?
Transition to Adult Care
1
2020
17
0.720
 Why?
Immunoglobulins, Intravenous
1
2021
55
0.710
 Why?
Bone Diseases, Developmental
2
2023
14
0.710
 Why?
Tooth Abnormalities
2
2023
12
0.710
 Why?
Oligonucleotides, Antisense
1
2020
28
0.690
 Why?
Phenobarbital
1
2020
17
0.690
 Why?
Behavioral Symptoms
1
2019
3
0.690
 Why?
Flunarizine
1
2019
1
0.690
 Why?
Immunologic Factors
1
2021
112
0.690
 Why?
Excitatory Amino Acid Antagonists
1
2020
50
0.680
 Why?
Ocular Physiological Phenomena
1
2019
4
0.670
 Why?
Tetrasomy
1
2019
2
0.670
 Why?
Agenesis of Corpus Callosum
2
2018
10
0.670
 Why?
Chromosomes, Human, Pair 5
1
2019
17
0.670
 Why?
Sneddon Syndrome
1
2019
3
0.670
 Why?
Livedo Reticularis
1
2019
6
0.660
 Why?
Oral Ulcer
1
2019
3
0.660
 Why?
Calcium Channel Blockers
1
2019
63
0.660
 Why?
Behcet Syndrome
1
2019
7
0.660
 Why?
Transposases
1
2019
10
0.650
 Why?
Andersen Syndrome
1
2019
1
0.650
 Why?
Spinal Cord Diseases
1
2019
37
0.650
 Why?
Hydrocephalus
1
2019
43
0.650
 Why?
Receptors, GABA-B
1
2019
11
0.650
 Why?
Vitiligo
1
2019
8
0.650
 Why?
Genetic Therapy
1
2020
117
0.650
 Why?
Nephrotic Syndrome
2
2017
18
0.640
 Why?
Leukoencephalopathies
1
2019
14
0.640
 Why?
Autoimmune Diseases of the Nervous System
1
2019
9
0.640
 Why?
Cytochrome-c Oxidase Deficiency
1
2018
3
0.640
 Why?
Migraine Disorders
2
2020
44
0.640
 Why?
Edema
1
2019
68
0.630
 Why?
Electron Transport Complex IV
1
2018
28
0.630
 Why?
Cerebral Infarction
1
2018
36
0.630
 Why?
Cannabinoid Receptor Agonists
1
2019
49
0.630
 Why?
Muscle Weakness
1
2019
44
0.630
 Why?
Physicians
1
2022
229
0.630
 Why?
Optic Atrophy
1
2018
16
0.630
 Why?
Diffuse Cerebral Sclerosis of Schilder
1
2018
8
0.620
 Why?
Amino Acyl-tRNA Synthetases
1
2018
6
0.620
 Why?
Shab Potassium Channels
1
2018
2
0.620
 Why?
Photic Stimulation
1
2018
59
0.620
 Why?
Alopecia
1
2019
37
0.620
 Why?
Brain Edema
1
2018
41
0.610
 Why?
Parents
1
2021
320
0.610
 Why?
Lymphohistiocytosis, Hemophagocytic
1
2018
27
0.610
 Why?
Thrombocytopenia
1
2019
79
0.610
 Why?
Autoimmune Diseases
1
2019
81
0.600
 Why?
Myoclonus
1
2018
9
0.600
 Why?
Artifacts
1
2018
53
0.600
 Why?
Biomedical Research
1
2021
241
0.600
 Why?
Mitochondrial Diseases
1
2018
42
0.600
 Why?
Neurodegenerative Diseases
1
2018
72
0.590
 Why?
Practice Guidelines as Topic
1
2020
458
0.590
 Why?
Hearing Loss, Sensorineural
1
2018
76
0.570
 Why?
Osteochondrodysplasias
1
2017
13
0.570
 Why?
Immunologic Deficiency Syndromes
1
2017
19
0.570
 Why?
Health Knowledge, Attitudes, Practice
1
2021
488
0.570
 Why?
Adolescent
13
2024
6417
0.560
 Why?
Models, Biological
1
2020
719
0.560
 Why?
Phenotype
2
2021
728
0.560
 Why?
Arteriosclerosis
1
2017
54
0.560
 Why?
Carotid Artery Diseases
1
2017
32
0.560
 Why?
Infant, Newborn
6
2024
2729
0.560
 Why?
Drug Discovery
1
2017
83
0.550
 Why?
Child Development
1
2018
190
0.550
 Why?
Prenatal Exposure Delayed Effects
1
2018
180
0.550
 Why?
Cafe-au-Lait Spots
1
2016
2
0.540
 Why?
Erythema Infectiosum
1
2015
3
0.530
 Why?
Migraine with Aura
1
2015
4
0.520
 Why?
Skin
1
2019
415
0.520
 Why?
Williams Syndrome
1
2016
26
0.520
 Why?
Leukoencephalitis, Acute Hemorrhagic
1
2015
3
0.520
 Why?
Corpus Callosum
2
2023
28
0.520
 Why?
Syndrome
6
2024
237
0.520
 Why?
Sinus Pericranii
1
2015
1
0.520
 Why?
Parvovirus B19, Human
1
2015
17
0.520
 Why?
Toes
1
2015
14
0.520
 Why?
Pulmonary Embolism
1
2017
98
0.520
 Why?
SOS1 Protein
1
2015
2
0.510
 Why?
Electrodiagnosis
1
2015
12
0.510
 Why?
Crying
1
2015
4
0.510
 Why?
Moyamoya Disease
1
2015
7
0.510
 Why?
Hyperventilation
1
2015
8
0.510
 Why?
Tuberculoma
1
2015
2
0.510
 Why?
Iatrogenic Disease
1
2015
24
0.510
 Why?
Epilepsy, Benign Neonatal
1
2015
2
0.510
 Why?
Noonan Syndrome
1
2015
12
0.510
 Why?
Neurologic Examination
1
2015
76
0.510
 Why?
Encephalitis
1
2016
40
0.500
 Why?
Mutism
1
2015
3
0.500
 Why?
Communication
3
2022
247
0.500
 Why?
NAV1.2 Voltage-Gated Sodium Channel
1
2015
3
0.500
 Why?
Ocular Motility Disorders
1
2015
17
0.500
 Why?
TOR Serine-Threonine Kinases
1
2015
76
0.490
 Why?
Repressor Proteins
2
2023
149
0.490
 Why?
Diagnosis, Differential
7
2020
1037
0.490
 Why?
Trisomy
1
2014
31
0.490
 Why?
Influenza, Human
1
2015
83
0.480
 Why?
Neurology
1
2015
36
0.470
 Why?
KCNQ2 Potassium Channel
1
2014
9
0.470
 Why?
Energy Drinks
1
2014
6
0.470
 Why?
Vasoconstriction
1
2014
55
0.470
 Why?
Benzodiazepines
1
2014
71
0.460
 Why?
Osteomyelitis
1
2015
125
0.460
 Why?
Membrane Proteins
1
2016
347
0.450
 Why?
Sleep
1
2014
179
0.440
 Why?
Enzyme Inhibitors
1
2015
378
0.430
 Why?
Magnetic Resonance Angiography
3
2019
72
0.410
 Why?
Immunosuppressive Agents
3
2019
226
0.400
 Why?
Pediatrics
1
2015
280
0.390
 Why?
Quality of Life
3
2022
838
0.370
 Why?
Receptors, N-Methyl-D-Aspartate
2
2022
127
0.360
 Why?
Diffusion Magnetic Resonance Imaging
3
2017
123
0.360
 Why?
Clinical Trials as Topic
2
2024
466
0.350
 Why?
Caregivers
2
2021
212
0.330
 Why?
Recurrence
3
2019
658
0.320
 Why?
Echinocandins
1
2008
64
0.310
 Why?
Mycoses
1
2008
158
0.290
 Why?
Gastroesophageal Reflux
2
2019
50
0.280
 Why?
Antifungal Agents
1
2008
343
0.260
 Why?
Administration, Topical
2
2015
56
0.260
 Why?
Retrospective Studies
6
2023
6124
0.250
 Why?
Seizures, Febrile
1
2024
2
0.240
 Why?
Meta-Analysis as Topic
1
2024
38
0.240
 Why?
Intralaminar Thalamic Nuclei
1
2024
6
0.230
 Why?
Adult
5
2024
13356
0.230
 Why?
Databases, Factual
2
2024
660
0.230
 Why?
Psychosurgery
1
2023
5
0.230
 Why?
Laser Therapy
1
2023
84
0.210
 Why?
Speech Disorders
1
2022
15
0.210
 Why?
Ethosuximide
1
2022
5
0.210
 Why?
Clonazepam
1
2022
5
0.210
 Why?
Electrodes, Implanted
1
2022
29
0.210
 Why?
Cluster Analysis
1
2023
233
0.210
 Why?
Stereotaxic Techniques
1
2022
37
0.210
 Why?
Death, Sudden
1
2022
10
0.200
 Why?
GTPase-Activating Proteins
1
2022
23
0.200
 Why?
Palliative Care
1
2024
185
0.200
 Why?
Concept Formation
1
2021
12
0.200
 Why?
Perivascular Epithelioid Cell Neoplasms
1
2021
4
0.200
 Why?
Freedom
1
2021
3
0.200
 Why?
Diazepam
1
2021
17
0.190
 Why?
Folic Acid
1
2022
137
0.190
 Why?
Drug Interactions
1
2022
209
0.190
 Why?
Fibroma
1
2021
39
0.190
 Why?
Risk Factors
2
2020
3605
0.190
 Why?
Adrenocorticotropic Hormone
2
2022
31
0.190
 Why?
Soft Tissue Neoplasms
1
2021
56
0.180
 Why?
Brain Diseases
1
2021
80
0.180
 Why?
Personal Satisfaction
1
2021
77
0.180
 Why?
Dihydroergotamine
1
2020
4
0.180
 Why?
Perception
1
2021
114
0.180
 Why?
Facies
2
2023
35
0.180
 Why?
Transcription Factors
2
2023
565
0.180
 Why?
Diet Therapy
1
2020
8
0.180
 Why?
Genetic Diseases, Inborn
1
2020
21
0.170
 Why?
Consensus
1
2021
155
0.170
 Why?
Clinical Protocols
1
2020
109
0.170
 Why?
Treatment Failure
1
2020
116
0.170
 Why?
Ubiquitin-Protein Ligases
1
2020
93
0.170
 Why?
Anesthetics
1
2020
36
0.170
 Why?
Leukomalacia, Periventricular
1
2019
12
0.170
 Why?
Muscle Hypotonia
1
2019
21
0.170
 Why?
Chromosomes, Human, Pair 7
1
2019
29
0.170
 Why?
Matrix Attachment Region Binding Proteins
1
2020
35
0.170
 Why?
Learning
1
2021
158
0.170
 Why?
HLA-B51 Antigen
1
2019
2
0.170
 Why?
Patient-Centered Care
1
2021
129
0.170
 Why?
Qualitative Research
1
2021
339
0.170
 Why?
Analgesics, Non-Narcotic
1
2020
115
0.170
 Why?
Craniofacial Abnormalities
1
2019
27
0.160
 Why?
Ventriculoperitoneal Shunt
1
2019
26
0.160
 Why?
Heart Septal Defects, Atrial
1
2019
44
0.160
 Why?
Potassium Channels, Inwardly Rectifying
1
2019
7
0.160
 Why?
Ventricular Premature Complexes
1
2019
7
0.160
 Why?
Disease Management
1
2020
175
0.160
 Why?
Microcephaly
1
2019
41
0.160
 Why?
Melkersson-Rosenthal Syndrome
1
2018
4
0.160
 Why?
Facial Nerve Diseases
1
2018
6
0.160
 Why?
Referral and Consultation
1
2021
285
0.160
 Why?
Syncope
1
2019
28
0.160
 Why?
Nocturnal Myoclonus Syndrome
1
2018
13
0.160
 Why?
Cerebral Veins
1
2018
15
0.160
 Why?
Facial Paralysis
1
2018
23
0.160
 Why?
Anti-Arrhythmia Agents
1
2019
81
0.160
 Why?
Deglutition Disorders
1
2019
75
0.160
 Why?
Acute Disease
1
2019
367
0.150
 Why?
Health Personnel
1
2021
254
0.150
 Why?
Fatal Outcome
1
2019
194
0.150
 Why?
Video Recording
1
2018
79
0.150
 Why?
Frameshift Mutation
1
2018
17
0.150
 Why?
Fibrinolytic Agents
1
2019
125
0.150
 Why?
Combined Modality Therapy
1
2020
638
0.150
 Why?
Anti-Inflammatory Agents
1
2019
160
0.150
 Why?
Fear
1
2018
84
0.150
 Why?
India
1
2017
52
0.150
 Why?
Platelet Aggregation Inhibitors
1
2019
174
0.150
 Why?
Cerebellum
1
2018
132
0.150
 Why?
History, 21st Century
1
2017
56
0.140
 Why?
History, 20th Century
1
2017
95
0.140
 Why?
Neurotoxicity Syndromes
1
2017
46
0.140
 Why?
Methotrexate
1
2017
72
0.140
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2017
84
0.140
 Why?
Anti-Infective Agents
1
2017
95
0.140
 Why?
Pandemics
1
2021
567
0.140
 Why?
Animals
3
2022
13100
0.140
 Why?
Aldehyde Dehydrogenase
1
2016
26
0.130
 Why?
Hormones
1
2016
57
0.130
 Why?
Influenza B virus
1
2015
6
0.130
 Why?
Delayed Diagnosis
1
2016
23
0.130
 Why?
Chromosomes, Human, Pair 3
1
2015
19
0.130
 Why?
North America
1
2015
65
0.130
 Why?
Arkansas
1
2021
1990
0.130
 Why?
Cerebral Angiography
1
2015
97
0.120
 Why?
Antibiotics, Antineoplastic
1
2015
77
0.120
 Why?
Chromosomes, Human, Pair 9
1
2014
19
0.120
 Why?
Complementary Therapies
1
2015
25
0.120
 Why?
Brain Waves
1
2014
18
0.120
 Why?
Drug Resistance
1
2015
64
0.120
 Why?
Antiemetics
1
2014
32
0.120
 Why?
Polymerase Chain Reaction
1
2015
456
0.120
 Why?
Headache
1
2014
75
0.110
 Why?
Vomiting
1
2014
71
0.110
 Why?
Glutamine
1
2015
169
0.110
 Why?
Mutation, Missense
1
2014
103
0.110
 Why?
Arginine
1
2015
178
0.110
 Why?
Analgesics
1
2014
100
0.110
 Why?
Decision Making, Computer-Assisted
1
2013
4
0.110
 Why?
Diagnostic Errors
1
2013
65
0.100
 Why?
Evidence-Based Medicine
1
2013
247
0.100
 Why?
Inflammation
1
2016
603
0.100
 Why?
Pregnancy
1
2018
2468
0.090
 Why?
Signal Transduction
1
2017
1608
0.090
 Why?
Antineoplastic Agents
1
2017
1175
0.080
 Why?
Dysentery
1
2009
1
0.080
 Why?
Trichuriasis
1
2009
1
0.080
 Why?
Trichuris
1
2009
1
0.080
 Why?
Anesthesia, Intravenous
1
2008
12
0.080
 Why?
Eosinophils
1
2009
43
0.080
 Why?
Lipopeptides
1
2008
63
0.080
 Why?
Amyloidosis
1
2009
77
0.080
 Why?
Inflammatory Bowel Diseases
1
2009
49
0.080
 Why?
Tuberculosis
1
2009
148
0.070
 Why?
Candidiasis
1
2008
114
0.070
 Why?
Aspergillosis
1
2008
125
0.070
 Why?
Kidney Diseases
1
2009
211
0.070
 Why?
Prospective Studies
2
2023
2345
0.070
 Why?
Spasm
1
2024
9
0.060
 Why?
Observer Variation
1
2024
136
0.060
 Why?
Feedback
1
2024
52
0.060
 Why?
Probability
1
2023
163
0.050
 Why?
Neuroimaging
1
2023
86
0.050
 Why?
Neurosurgical Procedures
1
2024
121
0.050
 Why?
Potassium Channels
1
2021
33
0.050
 Why?
Registries
1
2024
523
0.050
 Why?
Reproducibility of Results
1
2024
1182
0.050
 Why?
Administration, Intravenous
1
2020
70
0.040
 Why?
Sleep Stages
1
2020
43
0.040
 Why?
Cognition
1
2022
311
0.040
 Why?
Age of Onset
1
2020
108
0.040
 Why?
Immunohistochemistry
1
2021
972
0.040
 Why?
Software
1
2013
273
0.020
 Why?
Internet
1
2013
261
0.020
 Why?
Young Adult
1
2020
4031
0.020
 Why?
Mebendazole
1
2009
2
0.020
 Why?
Antinematodal Agents
1
2009
3
0.020
 Why?
Leukemoid Reaction
1
2009
6
0.020
 Why?
Antitubercular Agents
1
2009
106
0.020
 Why?
Colonoscopy
1
2009
96
0.020
 Why?
Prognosis
1
2009
1957
0.010
 Why?
Samanta's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (329) concept(s)
_
Co-Authors Expand Description
See all (13) people
_
Similar People Expand Description
See all (32) people
_
Same Department Expand Description
Search Department